Regulatory fines and penalties definition

Regulatory fines and penalties means those sums any Insured is required to pay as part of the settlement or judgment of a Privacy Regulatory Action to which this insurance applies.
Sample 1Sample 2Sample 3
Regulatory fines and penalties means any administrative fines and penalties an Insured is legally required to pay because of a claim covered under Coverage 3.
Sample 1Sample 2Sample 3
Regulatory fines and penalties means any civil fines and penalties imposed against an insured as a result of a government investigation.
Sample 1Sample 2

Examples of Regulatory fines and penalties in a sentence

  • Material elements of the right of access would therefore only be determined by further agreement.

  • In general, ignoring line type, perceptual trials were bisected further to the left for controls participants compared to archers.Archers showed a similar pattern of performance as found by Darling and colleagues (2012).

  • Regulatory fines and penalties Coverage: Cyber insurance policies provide cover for fines and penalties "to the extent insurable by law" i.e. the law applicable to the policy and the jurisdiction in which the payment is to be made.

  • Regulatory fines and penalties imposed upon Heinz or ADC shall be paid by Heinz by the date on which the payment is due.

  • EPCA desired that IGL will report progress on this issue to EPCA within a month.

  • We have however not made the detailed examination of the cost records with a view to determine whether they are accurate or complete.

  • Potential business impacts on security incidents can include: > Lost IP> Business interruption> Regulatory fines and penalties> Legal and PR fees> Remediation costs> Reputation AICPA has recently developed a cybersecurity risk management reporting framework that includes a new System and Organization Controls (SOC) for Cybersecurity engagement, through which the enterprise-wide cybersecurity risk management program is reviewed.

  • Regulatory fines and penalties are being much more frequently levied for violations, often involving a number of regulatory agencies who take action for the same or similar issues.

  • Regulatory fines and penalties will include such amounts imposed by the Business Conduct Committee and/or the Board, but not late charges or interest charged.

  • Maintenance or monitoring costs will not be allowed as part of the loan.


More Definitions of Regulatory fines and penalties

Regulatory fines and penalties means civil fines, civil monetary penalties, or amounts deposited into a consumer redress fund, imposed in a Regulatory Proceeding, but only to the extent they are insurable.
Sample 1Sample 2
Regulatory fines and penalties means civil fines or civil monetary penalties imposed for a breach of anydata protection law by a government agency, or governmental licensing or regulatory organisation, pursuant to an order resulting from a Regulatory Claim, but only to the extent they are insurable; provided, that Regulatory Fines and Penalties do not include fines or penalties imposed by any private or industry association regulatory organisation.
Sample 1Sample 2
Regulatory fines and penalties means those administrative, non-criminal fines or penalties an Insured becomes legally obligated to pay as a result of a covered regulatory violation claim or billing practices claim.
Sample 1
Regulatory fines and penalties means those sums any Insured is required to pay as part of the settlement or judgment of a Privacy Regulatory Action to which this insurance applies.Z Regulatory Restitution means sums deposited into a fund for the purpose of providing compensation to individuals affected by a Privacy Breach as part of a settlement or judgment resulting from a Privacy Regulatory Action.AA. Security Event means any of the following arising from a Wrongful Act taking place on or after the Retroactive Date, if any, shown in Item 8 of the Declarations:
Sample 1
Regulatory fines and penalties means civil fines or penalties imposed by a Regulatory Authority against an Insured as a result of a Privacy Regulatory Proceeding. “Regulatory Fines and Penalties” does not include any amounts deemed uninsurable under the law pursuant to which this Policy is construed, criminal fines or penalties of any nature or PCI DSS Fines and Assessments.
Sample 1

Related to Regulatory fines and penalties

  • Published Penalties means any additional published cancellation penalties levied by Your travel agency or Travel Supplier that apply to all clients of the travel agency or Travel Supplier and can be documented at time of Your purchase of Travel Arrangements from Your travel agency. The maximum amount reimbursable for travel agency published penalties is 25% of the total trip cost excluding taxes and other non-commissionable items.

  • Regulatory Submissions means all applications, filings, dossiers and the like submitted to a Governmental Authority for the purpose of obtaining Regulatory Approval.

  • Regulatory Filing means any filing with any Governmental Authority with respect to the research, development, manufacture, distribution, pricing, reimbursement, marketing or sale of a Product.

  • Regulatory Filings means any submission to a Regulatory Authority of any appropriate regulatory application together with any related correspondence and documentation, and will include any submission to a regulatory advisory board, marketing authorization application, and any supplement or amendment thereto.

  • CAISO Penalties means any fees, liabilities, assessments, or similar charges assessed by the CAISO for (a) violation of the CAISO Tariff and all applicable protocols, WECC rules or CAISO operating instructions or orders or (b) as a result of Seller’s failure to follow Prudent Electrical Practices. “CAISO Penalties” do not include the costs and charges related to Scheduling and imbalances as addressed in Section 14.1 of this Agreement.

  • Statutory Penalties are those amounts awarded as a penalty, but are fixed in amount by statute.

  • Adverse drug reaction means any undesirable or unexpected medication related event that requires discontinuing a medication or modifying the dose, requires or prolongs hospitalization, results in disability, requires supportive treatment, is life-threatening or results in death, results in congenital anomalies, or occurs following vaccination.

  • Regulatory Approval Application means any application submitted to an appropriate Regulatory Authority seeking any Regulatory Approval.

  • Regulatory Floodway means the channel of a river or other watercourse and the adjacent land areas that must be reserved in order to discharge the base flood without cumulatively increasing the water surface elevation more than a designated height.

  • Regulatory Materials means, with respect to a Licensed Product for any particular indication in any particular jurisdiction, regulatory applications and submissions (and any supplements or amendments thereto), and any notifications, communications, correspondence, registrations, drug master files, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority, including BLAs and INDs, as applicable, that relate to such Licensed Product in such jurisdiction. Regulatory Materials also include presentations, responses, and applications for Regulatory Approvals.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Marketing Authorization Application or “MAA” means an application for Regulatory Approval in a country, territory or possession.

  • IND means (a) an Investigational New Drug Application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA, or (b) the equivalent application to the equivalent agency in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction.

  • Investigational Product means the Study Drug identified above and the control material, as further detailed in the Protocol;

  • IDEQ means the Idaho Department of Environmental Quality.

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.

  • Regulatory Documentation means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).

  • Regulatory Conditions means the conditions set out in paragraphs 3.3 to 3.5 (inclusive) of Part A of Appendix I to the Announcement;

  • BLA means a Biologics License Application under the United States’ Public Health Services Act and Federal Food, Drug and Cosmetics Act, each as amended, and the regulations promulgated thereunder, or a comparable filing seeking Regulatory Approval in any country.

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Regulatory Documents means the prospectus, annual report, semi-annual report and any other document required under applicable federal securities law to be delivered by the Trust to Fund shareholders.

  • national regulatory authority means the body or bodies charged by a Member State with any of the regulatory tasks assigned in this Directive and the Specific Directives;

  • Regulatory Approvals means any registrations, licenses, authorizations, permits or approvals issued by any Governmental Authority and applications or submissions related to any of the foregoing.

  • MHLW means the Japanese Ministry of Health, Labour and Welfare, and any successor agency thereto.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.